LGP Little Green Pharma Ltd
- 0.100
- -0.005-4.76%
Little Green Pharma Ltd News
Little Green Pharma Ltd's (ASX:LGP) Profit Outlook
Little Green Pharma Ltd: Appendix 4E and 2024 Annual Report
Little Green Pharma Continues to Shine in a Paddock of Pot Stock Weeds
The uptake of medicinal cannabis products in Australia continues to boom, but most providers of the herbaceous material are not reaping the benefits because of oversupply, commoditised pricing and inv
Estimating The Intrinsic Value Of Little Green Pharma Ltd (ASX:LGP)
Little Green Pharma Price Target Raised 6.3% to A$0.17/Share by Canaccord Genuity
Little Green Pharma Price Target Raised 6.3% to A$0.17/Share by Canaccord Genuity
Signet Jewelers to Allocate Up to $1.1B to a Combination of Retiring Outstanding Debt, Retiring Preferred Shrs and Repurchase of Common Shrs in FY25 >SIG
Signet Jewelers to Allocate Up to $1.1B to a Combination of Retiring Outstanding Debt, Retiring Preferred Shrs and Repurchase of Common Shrs in FY25 >SIG
Signet Jewelers FY24 Adj EPS $10.37 >SIG
Signet Jewelers FY24 Adj EPS $10.37 >SIG
Little Green Pharma Ships First Shipment of High-THC Desert Flame Cannabis Flower Products to Poland; Shares Decline 9%
Little Green Pharma (ASX:LGP) shipped its inaugural batch of LGP-branded high-THC Desert Flame cannabis flower products to Poland, according to a Wednesday release. The shipment marks the end of a thr
Little Green Pharma Receives $5m R&D Rebate
Little Green Pharma (ASX:LGP) has received a $5 million research and development (R&D) rebate, its largest to date.
Little Green Pharma's Cherry Co Brand Flourishes After December Launch
Little Green Pharma (ASX:LGP) has released its quarterly activities report for December 2023, reporting a 25 per cent increase in revenue to $18.1 million.
Little Green Pharma's Psychedelics Subsidiary Opens Major Depressive Disorder Trial; Shares Fall 3%
Little Green Pharma's (ASX:LGP) psychedelics subsidiary, Reset Mind Sciences, launched a clinical trial investigating the use of the hallucinogenic drug psilocybin in combination with therapy to addre
Little Green Pharma Welcomes New Law for Supply of Medicinal Cannabis Oils in France; Shares Rise 4%
Little Green Pharma (ASX:LGP) welcomed the signing into law of new amendments to the existing social security financing order in France for the supply of medicinal cannabis products in the country. Th
Little Green Pharma (ASX:LGP) Sponsored Study Shows Medicinal Cannabis Enhances Quality of Life
Little Green Pharma CEO Stepping Down
Little Green Pharma (ASX:LGP) said Chief Executive Fleta Solomon will transition into an executive director role, effective at the end of August. Paul Long, the current chief operating officer, will t
Little Green Pharma (ASX:LGP) Promotes Paul Long to CEO
Poland Green Lights Little Green Pharma
Little Green Pharma (ASX:LGP) has announced that its Desert Flame high THC (20%) medicinal cannabis flower product has received Marketing Authorisation in Poland. This marks a significant milestone fo
Little Green Pharma (ASX:LGP) Delivers Record Revenue and Cash Receipts in Q4
Little Green Pharma Secures Supply Tender for French Cannabis Trial; Shares Jump 8%
Little Green Pharma (ASX:LGP) secured an up to 1 million euros tender to supply its CBD50 product to the government-led French medicinal cannabis trial. The trial serves as an entry point to supply me
Little Green Pharma (ASX:LGP) Wins French Trial Tender for CBD50
Little Green Pharma's (ASX:LGP) Subsidiary Pens Five Year Property Lease
Analysis
Price Target
No Data
